Director of FDA Drug Evaluation Unit Placed on Leave, NY Times Reports

FDA Director Placed on Leave, Raising Questions About Center's LeadershipThe director of the FDA's Center for Drug Evaluation and Research was suddenly placed on administrative leave, sparking speculation about the reasons behind this move. The center plays a crucial role in ensuring the safety and effectiveness of medications in the US. With no immediate comment from the agency, the lack of information has fueled rumors about regulatory decisions, internal conflicts, or possible reviews of recent agency actions. As the story unfolds, people close to the situation and staff members at the FDA are reacting with surprise, while the health industry closely watches for updates. The FDA is expected to provide more information soon, as the agency's daily work continues under acting leadership. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.